GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Accelrys, Inc. (ACCL) [hlAlert]

Rating:
Outperform
ACCL
up 60.17 %

Accelrys, Inc. (ACCL) upgraded to Outperform with price target $10 by Northland Securities

Posted on: Friday,  Jun 15, 2012  8:25 AM ET by Northland Securities

Northland Securities rated Outperform Accelrys, Inc. (NASDAQ: ACCL) on 06/15/2012, when the stock price was $7.81. Since
then, Accelrys, Inc. has gained 60.18% as of 04/29/2014's recent price of $12.51.
If you would have followed this Northland Securities's recommendation on ACCL, you would have gained 60.17% of your investment in 683 days.

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2012 8:25 AM Buy
None
7.81 10.00
as of 12/31/2012
1 Week down  -4.13 %
1 Month up  2.72 %
3 Months up  4.50 %
1 YTD up  15.87 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/4/2011 9:25 AM Hold
None
6.25
2/7/2008 9:25 AM Buy
None
6.42 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy